reslizumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

Anesthesia Central

-- The first section of this topic is shown below --

General

Pronunciation:
res-liz-ue-mab

Trade Name(s)

  • Cinqair

Ther. Class.
antiasthmatics

Pharm. Class.
monoclonal antibodies
interleukin antagonists

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - reslizumab ID - 110405 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab PB - F.A. Davis Company ET - 16 DB - Anesthesia Central DP - Unbound Medicine ER -